Drug prescribing in renal failure: dosing guidelines for adults.
about
Evaluation of plasmapheresis on the removal of tobramycin.Renal failure in children with hepatic failure undergoing liver transplantation.Dihydrocodeine in renal failure: further evidence for an important role of the kidney in the handling of opioid drugs.Chronic pain and analgesic use in CKD: implications for patient safety.Pharmacokinetics of cefonicid in patients with skin and skin structure infections.Double-blind randomized study of the effect of infusion rates on toxicity of amphotericin BEvaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic ModelOral and dental aspects of chronic renal failure.Pattern and Predictors of Medication Dosing Errors in Chronic Kidney Disease Patients in Pakistan: A Single Center Retrospective AnalysisDosing of antimicrobial agents in critically-ill patients with acute kindey injury and continuous venvenous haemofiltration.The role of albumin in human physiology and pathophysiology, Part III: Albumin and disease states.Varicella encephalitis and pneumonia in a patient with end stage renal failure.Interactions of albumin and medications.A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project.Phenytoin removal by continuous venovenous hemofiltration.Human infection with herpes zoster: etiology, pathophysiology, diagnosis, clinical course, and treatment.Pharmacokinetics of imipenem-cilastatin in patients with renal insufficiency undergoing continuous ambulatory peritoneal dialysis.Pharmacogeriatrics.Pharmacokinetics of continuous renal replacement therapy.Clinical pharmacokinetics of lithium.Evaluation of High-Dose Daptomycin Versus Vancomycin Alone or Combined with Clarithromycin or Rifampin Against Staphylococcus aureus and S. epidermidis in a Novel In Vitro PK/PD Model of Bacterial Biofilm.Cisplatin dose adjustment in patients with renal impairment, which recommendations should we follow?Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKD.Pharmacokinetics and dosage adjustment of antibiotics during continuous extracorporeal lung assistance and hemofiltration.Evaluation and first validation study on a simplified drug dosage algorithm for multiple organ failure patients.Evaluation of creatinine clearance estimation in an elderly male population.Nifedipine as an antihypertensive drug in patients with renal failure--pharmacokinetics and effects.
P2860
Q33495259-C75AD031-DC2D-4693-AB30-55FBD7233549Q34292210-3D6C5886-1A61-4B98-B9A8-FA48F5BEA892Q34491260-624369F6-960D-413C-9A0A-3BB75E854FF4Q35144435-B38F3C35-53AD-4099-9B51-173CB36DD557Q35298785-073B2C7F-0005-426E-A9A9-CBE976B7F6BDQ35843584-73DB8B66-559E-4797-BF23-1CB5996CD865Q35859931-41D8D3FB-15FD-4A8F-B1B8-9BB3EE6F6FD2Q36050817-67EC0F7C-B37F-447B-81D8-F0BCF082D259Q36066029-0FC1EA7F-6FE8-4D50-B95B-73532C26477DQ37088305-794D2CCC-D485-4A73-A643-1E2BB7F88017Q37309770-28C806D2-2522-4223-AFDE-8DA1A843801AQ37681805-1ACFD455-D80F-4836-B5E1-2344C47477B1Q37761947-A5DB9013-753C-40F0-AF14-57C371361EA7Q37895002-387C5A77-6C94-405D-8221-3016B6A831FEQ38164694-E7264728-6F50-4B54-AE75-7F0EB84BCFFAQ39643357-B6682E0D-5DB3-48C6-A602-3A54ADCF301DQ39817988-9FA1E4A3-6E23-480F-A214-847FC8011C7CQ39837842-DD63EFD9-BBF4-449E-A492-49B8737C17B5Q40434373-029AB6F6-4F07-4A1F-839D-FE63C6AFCF62Q40658310-75CFF42E-C07F-45CE-BBC4-20B55EA33ABAQ41593734-1C28D06D-9188-4321-B2FD-06FBC58BC003Q50732583-4CC5B9D5-261B-41C7-9433-834A8A8B6805Q51349873-D953161E-E758-4066-BEA2-824B8705695DQ52412207-91ED7545-7FA5-4148-AD1A-4F637795A3D3Q52433041-ADC971BD-A075-44C0-8D04-0CF34B57B475Q52869528-92888786-6796-4A98-9FA6-A3856E0242B5Q54324711-50A4D6EB-553C-4720-AD18-1C54FF1C1935
P2860
Drug prescribing in renal failure: dosing guidelines for adults.
description
1983 nî lūn-bûn
@nan
1983 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Drug prescribing in renal failure: dosing guidelines for adults.
@ast
Drug prescribing in renal failure: dosing guidelines for adults.
@en
Drug prescribing in renal failure: dosing guidelines for adults.
@nl
type
label
Drug prescribing in renal failure: dosing guidelines for adults.
@ast
Drug prescribing in renal failure: dosing guidelines for adults.
@en
Drug prescribing in renal failure: dosing guidelines for adults.
@nl
prefLabel
Drug prescribing in renal failure: dosing guidelines for adults.
@ast
Drug prescribing in renal failure: dosing guidelines for adults.
@en
Drug prescribing in renal failure: dosing guidelines for adults.
@nl
P2093
P1476
Drug prescribing in renal failure: dosing guidelines for adults.
@en
P2093
Aronoff GR
Bennett WM
Morrison G
P304
P356
10.1016/S0272-6386(83)80060-2
P577
1983-11-01T00:00:00Z